A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas

Abroad (travel likely)RecruitingPHASE2

Conditions

Glioblastoma · Brain Tumor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland, Ohio, United States
Contact: Study coordinator (David Peereboom, MD) · TaussigResearch@ccf.org · 866-223-8100
Contact: Principal Investigator (David Peereboom, MD)

Study leads

David Peereboom, MD
Principal Investigator
Case Comprehensive Cancer Center, Cleveland Clinic Taussig Cancer Institute

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

Glioblastoma · Anaplastic Astrocytoma · Anaplastic Oligoastrocytoma

Abroad (travel likely)RecruitingPHASE2

New York, United States

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Solid Tumors · Advanced Cancer · Renal Cancer

Abroad (travel likely)RecruitingPHASE2

Los Angeles, United States · Tampa, United States

The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.

Glioblastoma · Glioblastoma Multiforme · Glioblastoma Multiforme of Brain

Abroad (travel likely)Recruiting

Ghent, Belgium · Tilburg, Netherlands

WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Glioblastoma, IDH-Wildtype · MGMT-Unmethylated Glioblastoma

Abroad (travel likely)RecruitingPHASE2

Chicago, United States · Warrenville, United States